Pharmacy in Global Health

42. Lächele M, Gabel J, Sunny-Abarikwu N, Ohazulike RE, Ngene J, Chioke JF, Heide L (2024) Screening for substandard and falsified medicines in Nigeria using visual inspection and GPHF-Minilab analysis: lessons learned for future training of health workers and pharmacy personnel. Journal of Pharmaceutical Policy and Practice 17: 2432471. doi: 10.1080/20523211.2024.2432471

41. Gabel J,Difäm-EPN Minilab Network, Martus P, Heide L (2024) Relationship between prices and quality of essential medicines from different manufacturers collected in Cameroon, the Democratic Republic of the Congo, and Nigeria. Am J Trop Med Hyg 111: 1378–1395, 2024. doi:10.4269/ajtmh.24-0309 

40. Gabel J, Häfele-Abah C, Heide L (2024) Universität Tübingen unterstützt kirchliche Gesundheitseinrichtungen in Nigeria. Pharmazeutische Zeitung 169 (21), 1433.  

39. Gabel J, Lächele M, Sander K, Gnegel G, Sunny-Abarikwu N, Ezinwanne Ohazulike R, Ngene J, Chioke JF, Häfele Abah C, Heide L (2024) Quality of essential medicines from different sources in Enugu and Anambra, Nigeria. Am J Trop Med Hyg 111: 179-195. doi: 10.4269/ajtmh.23-0837

38. Gabel J, Gnegel G, Kessler W, Sacré PY, Heide L (2023) Verification of the active pharmaceutical ingredient in tablets using a low-cost near-infrared spectrometer. Talanta Open 8, 100270. doi: 10.1016/j.talo.2023.100270 

37. Hagen N, Hauk C, Heide L (2022) Trade in substandard and falsified medicines. In: Brombacher D, Maihold G, Müller M, Vorrath J, eds.: Geographies of the illicit. Linking the Global South and Europe. Reihe ‘Weltwirtschaft und internationale Zusammenarbeit’, Nomos Verlagsgesellschaft, Baden-Baden. doi: 10.5771/9783748935940-191 

36. Hauk C, Boss M, Gabel J, Schäfermann S, Lensch HPA, Heide L (2022) An open-source smartphone app for the quantitative evaluation of thin-layer chromatographic analyses in medicine quality screening. Sci Rep 12:13433. doi: 10.1038/s41598-022-17527-y 

35. Gnegel G, Häfele-Abah C, Neci R, Difäm-EPN Minilab Network, Heide L (2022) Surveillance for substandard and falsified medicines by local faith-based organizations in 13 low- and middle-income countries using the GPHF Minilab. Sci Rep 12:13095. doi: 10.1038/s41598-022-17123-0 

34. Masinia T, Macéb C, Heide L, Hamill H, Hampshire K, Newton PN, Ravinetto R (2022) Out of the boxes, out of the silos: The need of interdisciplinary collaboration to reduce poor-quality medical products in the supply chain. Res Social Adm Pharm 18: 3694-3698. doi: 10.1016/j.sapharm.2022.03.006

33. Hauk C, Hagen N, Heide L (2021) Identification of substandard and falsified medicines: Influence of different tolerance limits and use of authenticity inquiries. American Journal of Tropical Medicine & Hygiene 104(5): 1936–1945. doi: 10.4269/ajtmh.20-1612

32. Bizimana T, Hagen N, Gnegel G, Kayumba PC, Heide L (2021) Quality of oxytocin and misoprostol in health facilities of Rwanda. PLoS ONE 16(1):e0245054. doi: 10.1371/journal.pone.0245054  

31. Hauk C, Schäfermann S, Martus P, Muzafarova N, Babaley M, Waning B, Heide L (2020) Quality assurance in anti-tuberculosis drug procurement by the Stop TB Partnership - Global Drug Facility: Procedures, costs, time requirements, and comparison of assay and dissolution results by manufacturers and by external analysis. PLoS ONE 15(12): e0243428. doi: 10.1371/journal.pone.0243428  

30. Hagen N, Bizimana T, Kayumba PC, Khuluza F, Heide L (2020) Stability of oxytocin preparations in Malawi and Rwanda: Stabilizing effect of chlorobutanol. American Journal of Tropical Medicine & Hygiene 103(5): 2129–2141. doi: 10.4269/ajtmh.20-0255 

29. Hagen N, Bizimana T, Kayumba PC, Khuluza F, Heide L (2020) Stability of misoprostol tablets collected in Malawi and Rwanda: Importance of intact primary packaging. PLoS ONE 15(9): e0238628. doi: 10.1371/journal.pone.0238628

28. Bizimana T, Kayumba PC, Heide L (2020) Prices, availability and affordability of medicines in Rwanda. PLoS ONE 15(8): e0236411. doi: 10.1371/journal.pone.0236411 

27. Heide L (2020) Fälscher nutzen Corona-Pandemie (Counterfeiters take advantage of Corona pandemic; in German). Pharmazeutische Zeitung 165: 1628-1629  

26. Gnegel G, Hauk C, Neci R, Mutombo G, Nyaah F, Wistuba D, Häfele-Abah C, Heide L (2020) Identification of falsified chloroquine tablets in Africa at the time of the COVID-19 pandemic. American Journal of Tropical Medicine & Hygiene 103: 73–76. doi: 10.4269/ajtmh.20-0363

25. Schäfermann S, Hauk C, Wemakor E, Neci R, Mutombo G, Ndze EN, Cletus T, Nyaah F, Pattinora M, Wistuba D, Helmle I, Häfele-Abah C, Gross H, Heide L (2020) Substandard and falsified antibiotics and medicines against noncommunicable diseases in western Cameroon and north-eastern Democratic Republic of Congo. American Journal of Tropical Medicine & Hygiene 103(2): 894–908. doi: 10.4269/ajtmh.20-0184  

24. Newton P, Bond KC, Heide L and 50 further signatories (2020) COVID-19 and risks to the supply and quality of tests, drugs, and vaccines. Lancet Glob Health 8(6):e754-e755. doi: 10.1016/S2214-109X(20)30136-4 

23. Hagen N, Felix Khuluza F, Heide L (2020) Quality, availability and storage conditions of oxytocin and misoprostol in Malawi. BMC Pregnancy and Childbirth (2020) 20:184. doi: 10.1186/s12884-020-2810-9 

22. Schäfermann S, Neci R, Ndze EN, Nyaah F, Pondo BV, Heide L (2020) Availability, prices and affordability of selected antibiotics and medicines against noncommunicable diseases in western Cameroon and northeast DR Congo. PLoS ONE 15(1): e0227515. doi: 10.1371/journal.pone.0227515  

21. Newton PN, Bond KC, Heide L and 156 further signatories (2019) Global access to quality-assured medical products: the Oxford Statement and call to action. Lancet Glob Health. 7(12):e1609-e1611. doi: 10.1016/S2214-109X(19)30426-7 

20. Eberhart B (2019) Harmful medicines. Pharmaceutical scientist Lutz Heide and his team from the University of Tübingen are investigating the occurrence of substandard and falsified medicines in African countries. Attempto University of Tübingen Magazine 50: 28-34.  

19. Schäfermann S, Wemakor E, Hauk C, Heide L (2018) Quality of medicines in southern Togo: Investigation of antibiotics and of medicines for non-communicable diseases from pharmacies and informal vendors. PLoS One. 2018 Nov 29;13(11):e0207911 .

18. Seeger K, Heide L (2018) Substandard and falsified medicines in developing countries [Minderwertige und gefälschte Arzneimittel in Entwicklungsländern] (Review). Pharmakon 6 (5), 371-378 .

17. Haefele-Abah C, Heide L (2018) Kurs „Pharmacy in Global Health“ an der Universität Tübingen. Pharmakon 6 (5), 400 .

16. Petersen A, Held N, Heide L, on behalf of the Difäm-EPN Minilab Survey Group (2017) Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab. PLoS One. 12(9):e0184165. doi: 10.1371/journal.pone.0184165  

15. Khuluza F, Heide L (2017) Availability and affordability of antimalarial and antibiotic medicines in Malawi. PLoS ONE 12(4): e0175399 .

14. Khuluza F, Kigera S, Heide L (2017) Low prevalence of substandard and falsified antimalarial and antibiotic medicines in public and faith-based health facilities of Southern Malawi. Am J Trop Med Hyg. 96: 1124–1135 .

13. Khuluza F, Kigera S, Jähnke RWO, Heide L (2016) Use of thin-layer chromatography to detect counterfeit sulfadoxine/pyrimethamine tablets with the wrong active ingredient in Malawi. Malaria J 15: 215 .

12. Ndalama A, Dzabala N, Heide L (2015) Study of Pharmacy at the College of Medicine, University of Malawi. PharmJournal, Kenyatta University Pharmacy Students Association, Edition 01 May - August 2015, 35-36.  

11. Weber M, Daniels R, Mwale C, Dzabala N, Heide L (2015) Als Studentin nach Afrika. Herstellung und Qualitätskontrolle von Dermatologika in Malawi. Deutsche Apotheker-Zeitung 155: 3234-3236.  

10. Dzabala N, Heide L (2014) Pharmaziestudium in Malawi. Pharmazeutische Zeitung 159: 4336- 4343.  

9. Heide L (2006) Artemisinin in traditional tea preparations of Artemisia annua (Letter). Trans R Soc Trop Med Hyg.100: 802 .

8. Mueller MS, Runyambo N, Wagner I, Borrmann S, Dietz K, Heide L (2004) Randomised controlled trial of a traditional preparation of Artemisia annua L. (Annual Wormwood) in the treatment of malaria. Trans R Soc Trop Med Hyg 98: 318-321 .

7. Räth K, Taxis K, Walz G, H. Gleiter CH, Li S-M, Heide L (2004) Pharmacokinetic study of artemisinin after oral intake of a traditional preparation of Artemisia annua L. (Annual Wormwood). Am J Trop Med Hyg 70: 128-132 .

6. Heide L, Müller M (2001) Malaria in Afrika: Wie hilfreich sind Arzneipflanzen? Z. Phytother. 22: 77-81.

5. Heide L (1993) Traditionelle Arzneipflanzen in der Gesundheitsversorgung der Dritten Welt: Möglichkeiten und Grenzen. Deutsche Apotheker-Zeitung 133, 2067-2077.

4. Heide L (1990) Pflanzliche Schneckengifte. Eine neue Chance zur Bekämpfung der Bilharziose? Deutsche Apothekerzeitung 130, 1723-1728.

3. Heide L (1987) Plant tissue culture and herbal medicines for developing countries. Plant Tissue Culture Letters 4, 48.

2. Heide L (1987) Medical supplies management in the cholera epidemic in Somalia 1985. Disasters 11, 205‑213 .

1. Shire Jama A, Heide L, Petersen A (1985) Colour coding of labels for essential drugs. Tropical Doctor 15, 195 .